Antisoma, Novartis lung cancer drug fails in study

Posted by Reuters: Business News on March 29, 2010

LONDON (Reuters) – British cancer specialist Antisoma suffered a body blow on Monday as a lung cancer drug being developed with Novartis failed in a late-stage trial, sending its shares plunging 70 percent.